TGFB1 and neoplasm: 56 well-characterized gene signatures/immune traits (Supplemental Table 6) that reflect specific tumor-related pathways (including T/B cell response, TGF-β signaling, IFN signaling, and others) in solid tumors (12) were also investigated for association with clinical outcomes.